Seema Gupta

Research Assistant Professor

Georgetown University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Seema Gupta is a Research Assistant Professor at Georgetown University, located in the United States. Her research primarily focuses on cancer therapy, specifically investigating mechanisms of resistance, the interplay between cancer cells and the tumor immune microenvironment, and the effects of radiation in immunotherapy. She has contributed to numerous recent publications exploring innovative strategies to enhance tumor response to treatments and the modulation of immune responses in the context of cancer therapies.

Articles (9)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Michael Grusch

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Seema Gupta

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Emerging concepts in cancer therapy: Mechanisms of resistance

Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer

Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?

Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment

Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors

MEK inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects

Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)

Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors

The concept of ‘iatrogenic resistance’: insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy

Collaborators (1)

Michael Grusch

Make your next move.